Nanotechnology Based Approaches for Drug Analysis in Pharmaceutical Formulations: A Comprehensive Review

Authors

  • N Sriram Professor, Holy Mary Institute of Technology and Science, College of Pharmacy, Bogaram, Keesara, Hyderabad, India.
  • Sidhartha Sankar Hota Associate Professor, Faculty of Pharmacy, C V Raman Global University, Bhubaneswar, Odisha. 752054.

Keywords:

nanotechnology, drug analysis, pharmaceutical formulations, characterization, quantification, quality control

Abstract

The advancement of nanotechnology has revolutionized the field of drug analysis in pharmaceutical formulations. Nanotechnology-based approaches offer unprecedented opportunities for the characterization, quantification, and quality control of drugs, contributing to enhanced safety and efficacy of pharmaceutical products. In this comprehensive review, we present an in-depth analysis of various nanotechnology-based techniques employed for drug analysis in pharmaceutical formulations. We discuss their principles, advantages, limitations, and potential applications, along with recent advancements in the field. Furthermore, we provide insights into the regulatory considerations and challenges associated with the implementation of nanotechnology-based approaches in the pharmaceutical industry. This review serves as a valuable resource for researchers, scientists, and regulatory bodies involved in drug analysis and formulation development.

Downloads

Published

2023-08-08

Issue

Vol. 9 No. 3 (2023): Vol 9. No 3 (2023) Volume - 9 Issue - 3

Section

Articles

License

Rights and reuse terms depend on the individual article record. Articles accepted on or after 8 September 2026 are licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), provided appropriate credit is given, a link to the licence is supplied and changes are indicated. Earlier content remains governed by the rights and licence notice applicable to that article and is not retrospectively relicensed by this policy. Third-party material identified under a different notice is excluded from the journal licence.